Sysmex ADR Cash Flow from Financial Activities 2016-2024 | SSMXY

Sysmex ADR cash flow from financial activities for the twelve months ending December 31, 2024 was $-0.295B, a 2.3% increase year-over-year.

  • Sysmex ADR annual cash flow from financial activities for 2024 was $-0.06B, a 66.72% decline from 2023.
  • Sysmex ADR annual cash flow from financial activities for 2023 was $-0.179B, a 1.91% decline from 2022.
  • Sysmex ADR annual cash flow from financial activities for 2022 was $-0.183B, a 0.2% increase from 2021.

Sysmex ADR Cash Flow from Financial Activities 2016-2024 | SSMXY

  • Sysmex ADR annual cash flow from financial activities for 2024 was $-0.06B, a 66.72% decline from 2023.
  • Sysmex ADR annual cash flow from financial activities for 2023 was $-0.179B, a 1.91% decline from 2022.
  • Sysmex ADR annual cash flow from financial activities for 2022 was $-0.183B, a 0.2% increase from 2021.
Related Stocks
Company NameMarket
Cap
Intuitive Surgical (ISRG)$185.1B
Thermo Fisher Scientific (TMO)$160.6B
Edwards Lifesciences (EW)$45.9B
Alcon (ALC)$43.1B
IDEXX Laboratories (IDXX)$42.7B
DexCom (DXCM)$33.5B
IQVIA Holdings (IQV)$27.7B
Mettler-Toledo (MTD)$24.8B
STERIS (STE)$22.2B
Waters (WAT)$18.1B
SONOVA HOLDING (SONVY)$17.2B
Hologic (HOLX)$14.4B
Penumbra (PEN)$9.3B
Masimo (MASI)$8.8B
Globus Medical (GMED)$7.8B
Glaukos (GKOS)$6B
Teleflex (TFX)$5.1B
Integer Holdings (ITGR)$4.2B
TransMedics (TMDX)$4B
PROCEPT BioRobotics (PRCT)$3.2B
LivaNova (LIVN)$2.4B
Nihon Kohden (NHNKY)$2.1B
Veracyte (VCYT)$2.1B
Elekta AB (EKTAY)$1.9B
Alphatec Holdings (ATEC)$1.6B
Artivion (AORT)$1.4B
Paragon 28 (FNA)$1.1B
Pulse Biosciences (PLSE)$1.1B
OPKO Health (OPK)$1.1B
Tandem Diabetes Care (TNDM)$1B